Intelligo

Private limited company · Bodø

POLAR BIOMEDICALS AS

ActiveWholesale of pharmaceutical and medical goods (46.460)

Founded
13 Aug 2004
Chief executive
Bjørn Tore Knudsen
Business address
Sivert Nielsens gate 63, 8007 Bodø

The life line 2004–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 30.0m.

  1. Chair took office§ 07
  2. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

POLAR BIOMEDICALS AS is a private limited company in Bodø, founded in 2004, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Bjørn Tore Knudsen, and the chair of the board is Bjørn Tore Knudsen. In 2025 the company had NOK 30.0m in operating revenue and a net profit of NOK 1.4m. The largest owner is KNUDSEN INVEST AS with 51.2%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 9 Oct 2026

  • Job advertisement: Selger til helse – fagbakgrunn eller erfaring fra tilsvarende firmaer
  • Annual accounts filed 2024 → 2025
  • Endring av styre
  • Won a tender from SYKEHUSINNKJØP HF

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

1 point

  • OKEquity ratio 64.7%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 30.0m in 2025

Revenue

NOK 30.0m

+0.9% from 2024

20232025

Operating profit

NOK 1.8m

−63.2% from 2024

20232025

Net profit

NOK 1.4m

−61.8% from 2024

20232025

Equity

NOK 11.4m

+4.1% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 7%
  • Depreciation 0%
  • Other operating costs 16%
  • Not specified in the source 71%
  • Left as operating result 6%

Of the net profit for 2025, NOK 446k stayed in the company. The rest, NOK 1.0m, is an assumed dividend.

The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 64.7%

RevenueNOK 30.0m Operating margin5.9% Equity ratio64.7% Revenue growth+0.9%
  • POLAR BIOMEDICALS AS, 2025
  • Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%

Equity NOK 11.4m65% of the assets (NOK 17.5m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.

Finances

§ 06 Accounts

22 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue29,99329,72427,126
Operating profit1,7724,8212,489
Profit before tax1,8014,8332,140
Net profit1,4463,7851,619
Total assets17,54517,16413,630
Equity11,35610,9107,925
Liabilities6,1886,2545,705

Source: the Register of Company Accounts, read 15 Nov 2026 · All 22 years →

Management and ownership

§ 07 Officers

6 officers now

The board: 3 members

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 6 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Styrets leder og ett styremedlem i fellesskap.

May sign for the company:

Styrets leder og ett styremedlem i fellesskap.

Power of procuration:

Styrets leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 24 Aug 2026

Management and ownership

§ 09 Owners

2 shareholders · largest 51.2%

OwnerShare
KNUDSEN INVEST AS
51.2%
ESPE HOLDING AS
32.2%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 2 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

3 connections

  • Person
  • Company

2 people link POLAR BIOMEDICALS AS to 3 other companies: Britt Hege Solli 2 and Bjørn Tore Knudsen 1.

Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

7 since 2015

Events per year

20152026

  • Notices4
  • Register changes1
  • Tenders won1
  • Job advertisements1

Since 2015: 4 announcements, 1 register change, 1 tender won and 1 job advertisement. Most happened in 2023 and 2025.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 16 Nov 2026. Register changes are Intelligo's own observations. · All 7 events →

Events and registers

§ 14 Notices

4, latest 8 May 2025

  • Styre
  • Godkjente årsregnskap
  • Revisor

Source: The Brønnøysund Register Centre's announcements ↗, read 16 Nov 2026 · All 4 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 13 Sep 2004
  • VATRegistered
  • The Register of Business EnterprisesRegistered 13 Sep 2004
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Kjøp og salg av varer til sykehus, redningstjenester, institusjoner, barnehager og lignende, samt drive annen virksomhet som naturlig hører sammen med dette.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

1 tender

  • 2025
  • Won
  • Lost
AwardedContractBuyerOutcome
Jan 2025Oppdekkingssett og operasjonsoppdekking til helseforetakene i Helse NordSYKEHUSINNKJØP HFWon

Source: Doffin and TED, read 10 Jul 2026. · All 1 tenders →

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 46.460

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of POLAR BIOMEDICALS AS?
    Bjørn Tore Knudsen. § 07
  • Who owns POLAR BIOMEDICALS AS?
    2 shareholders. The largest is KNUDSEN INVEST AS with 51.2% and ESPE HOLDING AS with 32.2%. § 09
  • What was the revenue in 2025?
    NOK 30.0m in the company. § 06
  • Who can sign for POLAR BIOMEDICALS AS?
    Styrets leder og ett styremedlem i fellesskap. § 08
  • Who is the auditor?
    NORDNORSK REVISJON AS, from 6 Nov 2023. § 07
  • Where is POLAR BIOMEDICALS AS based?
    Sivert Nielsens gate 63, 8007 Bodø.
  • When was POLAR BIOMEDICALS AS founded?
    13 Aug 2004, registered in the Register of Business Enterprises 13 Sep 2004. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose